RESPIRATORY SYNCYTIAL VIRUS INFECTION
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New mRNA vaccine aims to shield seniors from two dangerous respiratory viruses
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested an experimental mRNA vaccine designed to prevent lower respiratory tract disease caused by RSV and hMPV viruses. About 558 healthy adults aged 18-49 and 60+ received a single shot at different doses. Researchers monitored safety and immune responses …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:34 UTC
-
Triple-Threat vaccine trial aims to shield seniors from three winter viruses
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested whether a new combination vaccine is safe and helps the body build defenses against three respiratory viruses: RSV, hMPV, and PIV3. About 390 adults aged 60 and older received different doses or combinations of the vaccine. Researchers monitored side…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:33 UTC
-
Promising RSV vaccine trial shows safety in young children
⭐️ VACCINE ⭐️ CompletedThis study tested a live-attenuated RSV vaccine in 259 infants and toddlers aged 6 to 18 months. The main goals were to check the vaccine's safety and measure the immune response. Researchers also looked at how much vaccine virus was shed and how many children got infected with t…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:02 UTC
-
New combo vaccine aims to shield seniors from two dangerous respiratory viruses
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine that targets two respiratory viruses—RSV and hMPV—in adults aged 60 and older. The goal was to see if the vaccine is safe and triggers a strong immune response. Participants received either a single shot or a booster after 12 months, and researcher…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:53 UTC
-
New RSV vaccine trial checks for spread in daycares
⭐️ VACCINE ⭐️ CompletedThis study tested a live, weakened RSV vaccine in healthy infants and toddlers aged 6 to 24 months in Puerto Rico. The main goal was to see if the vaccine virus spreads to other children in the same home or daycare, and to check its safety and immune response. 80 children took pa…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:57 UTC
-
New RSV vaccine shows promise for seniors in major trial
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental RSV vaccine in about 4,500 adults aged 60 and older. Half received the vaccine and half received a placebo. The goal was to see if the vaccine could prevent lower respiratory tract disease caused by RSV, a common virus that can be serious in olde…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:54 UTC
-
New study tests best way to protect babies from RSV
Prevention CompletedThis study looked at two new ways to prevent RSV, a serious lung infection in babies. Researchers compared giving a vaccine to pregnant women, giving a long-acting antibody shot to infants, or using both. The goal was to see how well each approach protects babies during their fir…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated May 26, 2026 04:36 UTC
-
New shot cuts RSV lung infections in infants by half, large trial shows
Prevention CompletedThis study tested a single shot of clesrovimab in over 3,600 healthy preterm and full-term infants to see if it could prevent serious RSV lung infections. The medicine was given before or during RSV season and compared to a placebo. Results showed fewer babies who got the shot ne…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 22, 2026 13:53 UTC